Invention Grant
- Patent Title: Multi-CBV vaccine for preventing or treating type 1 diabetes
-
Application No.: US16995439Application Date: 2020-08-17
-
Publication No.: US11633468B2Publication Date: 2023-04-25
- Inventor: Hyöty Heikki , Mikael Knip , Olli Laitinen , Outi Tolonen , Minna Pulkki , Sami Oikarinen , Hanna-Riikka Honkanen , Valérie Lecouturier , Jeffrey Almond , Malin Flodström-Tullberg
- Applicant: Vactech Oy
- Applicant Address: FI Tampere
- Assignee: Vactech Oy
- Current Assignee: Vactech Oy
- Current Assignee Address: FI Tampere
- Agency: Bozicevic Field & Francis, LLP
- Agent Paula A. Borden
- Priority: EP11306344 20111018
- Main IPC: A61K39/125
- IPC: A61K39/125 ; A61K39/12 ; C07K16/10 ; A61K39/13 ; A61K39/39 ; A61K39/00
Abstract:
The invention is directed to a vaccine comprising: i) coxsackie B virus CBV1 and CBV2, and ii) at least one coxsackie B virus selected from CBV3, CBV4, CBV5 and CBV6. The CBVs are present in the vaccine in inactivated form, in the form of a component of the virus or as an antibody against the virus. The vaccine is effective in preventing and treating type 1 diabetes. So is an anti-coxsackie B virus composition provided.
Public/Granted literature
- US20210023196A1 MULTI-CBV VACCINE FOR PREVENTING OR TREATING TYPE I DIABETES Public/Granted day:2021-01-28
Information query
